SoluLinK, Inc. Announces IRS Federal Grant Award to Advance its New Multiplexing and Detection Technology for Research and Diagnostics Applications Used for Accelerating Therapeutics Development
9/15/2011 12:06:53 PM
More...
|
SoluLinK, Inc. Awarded Phase I SBIR Contract to Develop a Multiplex Screen for the Rapid Detection of Breast Cancer
9/15/2011 12:04:33 PM
More...
|
SoluLinK, Inc. Awarded SBIR NIAID Phase I Grant for Development of a Multiplexed Vaccine Titer Assay
9/15/2011 11:59:29 AM
More...
|
SoluLinK, Inc. Introduces First-Ever Kits for Antibody-Oligonucleotide Preparation without Chromatography
9/15/2011 11:57:18 AM
More...
|
SoluLinK, Inc. Introduces Product that Links All Biomolecules Greater Than 20 Times Faster with 100% Yields
9/15/2011 11:55:27 AM
More...
|
SoluLinK, Inc. Introduces First-Ever Digoxigenin Antibody Labeling Kit with Built-in Quantification
9/15/2011 11:44:33 AM
More...
|
SoluLinK, Inc. Announces DARPA SBIR Contract Award
9/15/2011 11:00:46 AM
More...
|
SoluLinK, Inc. Introduces First-Ever Digoxigenin Antibody Labeling Kit with Built-in Quantification
9/15/2011 10:59:05 AM
More...
|
SoluLinK, Inc. Introduces a Breakthrough All-in-One Conjugation Kit: The New HRP-Antibody Conjugation Kit for Simple, Direct Conjugation of Enzymes to Antibodies
9/15/2011 10:55:24 AM
More...
|
SoluLinK, Inc. Announces Higher Binding Streptavidin Agarose
9/12/2011 9:32:10 AM
More...
|
|